Zephyrnet Logo

Tag: IBS

Cloud Adoption in Financial Services Poised to Take Off

The financial sector is undergoing a major shift where institutions are now migrating to the cloud, moving away from slow manual processes and costly on-premise systems to start benefiting from

The post Cloud Adoption in Financial Services Poised to Take Off appeared first on Fintech Singapore.

MonetaGo Appoints Oswald Kuyler to Lead Expansion Into Europe

LONDON, SINGAPORE & NEW YORK–(BUSINESS WIRE)–#MonetaGo–Financial technology solutions provider MonetaGo today announced the launch of operations in Europe, effective March 1, 2022, and the appointment of Oswald Kuyler to the newly created role of head of strategy, Europe. Based in London, Kuyler will lead MonetaGo’s European expansion, spearheading the company’s growth in the region and […]

The post MonetaGo Appoints Oswald Kuyler to Lead Expansion Into Europe appeared first on Fintech News.

Cannabis suppositories: Would you try kush for your tush?

After three years of legalization, cannabis suppositories have finally hit the retail market. But are Canadians ready?

The post Cannabis suppositories: Would you try kush for your tush? appeared first on Leafly.

Wellness Design And Wellness Precautions Will Feature Heavily At 2022 Kitchen & Bath Industry Show

The 2022 Kitchen & Bath Industry Show will return to Orlando on February 8, after going virtual last year.

MonetaGo Commences Japan Operations led by Munetoshi Yamada

TOKYO, SINGAPORE & NEW YORK–(BUSINESS WIRE)–#MonetaGo—MonetaGo is pleased to announce the launch of operations in Japan beginning effective immediately. The Japanese business is led by Mr. Munetoshi Yamada, Managing Director Japan, based in Tokyo. Yamada-san brings with him a wealth of experience in the thriving Japanese financial sector having proven himself a senior leader at […]

The post MonetaGo Commences Japan Operations led by Munetoshi Yamada appeared first on Fintech News.

How 15 Minutes of Strength Training Can Reduce Pain Via Endocannabinoid System

We all know working out is good, even if we don’t like doing it. Now, new research sheds light on just how strength training effects the endocannabinoid system, and how this in turn can help reduce pain and inflammation. And it brings several implications with it. Let’s be honest, exercise is good and we should […]

The post How 15 Minutes of Strength Training Can Reduce Pain Via Endocannabinoid System appeared first on CBD Testers.

Is Big Pharma Weed Coming with Pfizer Buying Arena Pharmaceutical’s Cannabinoid Business?

However, the news of Pfizer wanting to break into the medical cannabis industry isn’t something new. Every advocate understood that once cannabis is legalized globally, these giant pharmaceutical companies would definitely make their claim to some portion of the marketplace. Whether this is a “good” thing or a “bad” thing is irrelevant – the truth of the matter is that pharma entering into the cannabis industry is an inevitability.

Weed and Gut Health

The way in which cannabis affects the stomach has been argued over for some time. Some believe that weed is great for gut health while others believe it can cause a variety of problems

The post Weed and Gut Health first appeared on Cannabis Seeds News.

Future of Identity-Based Security: All-in-One Platforms or Do-It-Yourself Solutions?

The functionality of all-in-one platforms is being deconstructed into a smorgasbord of services that can be used to develop bespoke end-user security procedures for specific work groups, lines of businesses, or customer communities.

Is Pfizer Buying Arena Pharmaceuticals to Get into the Cannabis Space or Do They Just Want IBS and Digestive Issue Drugs?

Mike Gladstone, global president and general manager of Pfizer Inflammation and Immunology unit, said that the acquisition of Arena is in line with the company's capabilities and expertise in immunology and inflammatory-related conditions. Over the years, Pfizer has successfully created an innovation engine that develops potential medicines for patients worldwide with chronic and debilitating immuno-inflammatory conditions. The company understands that there is an urgent need to look into other treatment options with high potential, which is where Arena's cannabinoid-drug pipeline comes in.

BNPL: High Reward, High Risk?

Buy Now, Pay Later has finished 2021 strong, the new payment model seeing strong adoption over the past 12 months particularly as the pandemic forced a number of shifts to consumer spending habits. The biggest platforms continue to expand – BNPL company Klarna recently extended its services to incorporate all online retailers, whether they’re Klarna partners or not – but while they and other players have reaped the rewards, the longer-term potential pitfalls of the product are only beginning to be visible as data becomes available. In a recent survey from Pipslay, some 43% of Gen Z respondents reported they’d

The post BNPL: High Reward, High Risk? first appeared on FinTech Rising.

Financial Inclusion in Latin America; A Look at Fintech Up ‘n’ Comers in Egypt

The Road to Greater Financial Inclusion in Latin America This week’s Finovate Global Reports takes a look at the drive for financial...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?